RxDoctor Payments Data

Amity Parker

Family · Lebanon, TNNPI 1770239436

Payments from drug & device makers

$13,943in general payments, 2019–2025

Across 347 payments — averaging $40.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$6K
  • AstraZeneca$615
  • Novartis$607
  • Lilly USA, LLC$571
  • Gilead$475
  • Merck$465
  • plus $6K from 54 others

What the payments were for

  • Consulting fees$5,25038%
  • Food & beverage$8,09358%
  • Education$6004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Daiichi Sankyo Inc.16$5,692
AstraZeneca(2 entities)27$615
Novartis21$607
Lilly USA, LLC15$571
Gilead(2 entities)13$475
Merck16$465
Johnson & Johnson15$368
Regeneron Healthcare Solutions, Inc.16$362
AVEO Pharmaceuticals, Inc.6$257
Pfizer13$254
E.r. Squibb & Sons, L.L.C.11$242
Sanofi8$228
AbbVie9$215
Karyopharm Therapeutics Inc.6$193
Tersera Therapeutics LLC9$178
Bristol Myers Squibb7$175
Pharmacosmos Therapeutics Inc.7$156
Exelixis Inc.7$148
Eisai Inc.7$145
Beigene USA, Inc.7$145
Incyte Corporation6$137
Pharmaessentia USA Corporation6$136
Bayer6$121
Genentech USA, Inc.6$110
Takeda Pharmaceuticals U.S.A., Inc.4$108
Pharmacyclics LLC, An Abbvie Company5$104
Taiho Oncology, Inc.6$103
Rigel Pharmaceuticals, Inc.5$100
Sanofi-aventis U.S. LLC1$100
Array Biopharma Inc5$99
EMD Serono, Inc.4$96
Seagen Inc.5$93
Mirati Therapeutics, Inc.4$82
ADC Therapeutics America, Inc.4$79
Ipsen Biopharmaceuticals, Inc3$78
GSK3$67
G1 Therapeutics, Inc.3$62
Puma Biotechnology, Inc.3$59
Sumitomo Pharma America, Inc.3$56
Jazz Pharmaceuticals Inc.2$49
Sobi, Inc2$47
Blueprint Medicines Corporation1$41
Astellas Pharma US Inc2$40
Novocure Inc.1$36
Morphosys, US Inc.2$36
Macrogenics, Inc.1$35
Coherus Oncology, Inc.1$35
Legend Biotech USA Inc.1$34
Stemline Therapeutics Inc.2$33
Amgen2$31
Agios Pharmaceuticals, Inc.2$31
Deciphera Pharmaceuticals Inc.1$26
Accord Healthcare, Inc.1$26
Sun Pharmaceutical Industries Inc.1$26
Servier Pharmaceuticals LLC1$23
Progenics Pharmaceuticals, Inc.1$22
Spectrum Pharmaceuticals Inc.1$22
Geron Corporation1$21
CTI Biopharma Corp.1$18
Boehringer Ingelheim1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,943 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$188,001
Medicare patients
64
Services billed
10,196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole29$582
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$325
Potassium Chloride26$236
Dexamethasone13$223
Folic Acid14$48

Paid to pharmacies, not to this prescriber.

Other family in Lebanon

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →